Size Still Matters: Minimizing Complications in REBOA
It’s been just over 2 years since we published our first COBRA-OS® study, “Size Matters; first-in-human study of a novel 4 French REBOA device.” Since that study, I have personally been using the device clinically and have been hearing stories about the COBRA-OS® from customers all over North America and beyond.
REBOA around the World: Complications, Training, Technology
Dr. Adam Power, our co-founder and CMO discussed REBOA complications, training and technology at the 5th World Coalition for Trauma Care Virtual Conference.
FDA Clears the Smallest Life-Saving Bleeding Control Device, COBRA-OS®
After three years of research and development, Front Line Medical Technologies introduces the world’s smallest REBOA device to control bleeding and help patients survive emergencies.